Adam Urato

Dr. Adam Urato, Chief of Maternal-Fetal Medicine at MetroWest Medical Center, dives deep into the troubling implications of medications during pregnancy. He discusses the risks associated with SSRIs and Tylenol, revealing research that links these drugs to developmental issues in children. Urato advocates for clearer FDA warnings, emphasizing the importance of informed decision-making for expectant mothers. He also explores the implications of medications like Adderall and highlights the need for better medication management before conception, urging more transparency in pharmaceutical messaging.

In this discussion, Dr. Adam Urato, a maternal-fetal medicine specialist, highlights the critical lack of informed consent regarding SSRI antidepressants during pregnancy. He explains how serotonin affects fetal development and the potential negative impacts of SSRIs on unborn children. The conversation also addresses the rise in medical interventions in pregnancy and questions whether the pharmaceutical industry contributes to doctors' indifference about these risks. Dr. Urato advocates for more compassionate care and awareness for expectant mothers facing mental health challenges.

Dr. Adam Urato, a Maternal-Fetal Medicine physician and advocate for medical freedom, joins the discussion to reveal unsettling truths about medication risks during pregnancy. He questions the adequacy of informed consent practices, exposing how less than ten minutes are often spent on this crucial topic. Dr. Urato emphasizes the need for rigorous safety evaluations and discusses the troubling approval of ineffective drugs. The conversation encourages open dialogue about alternative mental health strategies and the ethical responsibilities of the medical community.